https://www.selleckchem.com/pr....oducts/sch-527123.ht
2-98.0% in six reports. Five studies reported actuarial LC (2-year LC 70.0-100%). PFS was reported as a crude rate in 11 studies (range 27.3-68.8%). Actuarial 2-year PFS was reported in four studies (range 30.0-50.0%). SBRT tolerability was excellent, with only two patients with grade 3 acute toxicity and two patients with grade 3 late toxicity. SBRT for LN oligorecurrences from PCa in safe and provides optimal LC. However, the long-term effect on PFS and OS is still unclear as well as which patients are the best candidate for this a
Beğen
Yorum Yap
Paylaş
